Radius Health (RDUS) Delay in U.S. 'Bad News', Maxim Group Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Radius Health (RDUS) Announces Submission of Abaloparatide MAA in Europe
November 17, 2015 8:35 AM ESTRadius Health (NASDAQ: RDUS) announced that it has submitted a Marketing Authorization Application (MAA) for an investigational, once-daily subcutaneous injection of abaloparatide, a novel synthetic peptide. In addition to other data, the MAA is supported by clinical studies exploring the use of abaloparatide for the treatment... More
Radius Health (RDUS) Sees Heavy Pressure
November 16, 2015 1:50 PM ESTRadius Health (NASDAQ: RDUS) is under heavy pressure ahead of tomorrow's Investor Day. Shares are down 6.4%.
... More